Skip to main content
. 2022 Nov 17;12:484. doi: 10.1038/s41398-022-02249-6

Fig. 1. Modular considerations for managing depressive symptoms and cognitive impairment.

Fig. 1

Through assessment of both cognitive and psychiatric presentation, future research may provide scope for the identification of appropriate polypharmacy for the individual case.